[1]
Q. Wang, “Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid Leukemia”, J Pharm Pharm Sci, vol. 23, no. 1, pp. 1–9, Jan. 2020.